New sales powered Swedish oncology firm Elekta to healthy growth in its year-end fiscal year 2009 results (end-April 30).
The Stockholm-based firm reported an 18% increase in net sales to 6.69 billion kronor ($869.6 million U.S.) in fiscal year 2009 compared to 2008. Net profit advanced to 546 million kronor ($70.9 million U.S) in fiscal year 2009 over fiscal year 2008.
The company also projected that net sales for fiscal year 2010 will increase by more than 8%, with operating profit gaining more than 35%.
Copyright © 2009 AuntMinnie.com